Johnston Erwin, TRexBio CEO

Ex­clu­sive: Eli Lil­ly boosts in­flam­ma­to­ry dis­ease pipeline, li­cens­es three can­di­dates from TRexBio

Eli Lil­ly is adding three new pre­clin­i­cal can­di­dates to its im­mune and in­flam­ma­to­ry med­i­cines ar­mory through TRexBio, a Bay Area biotech that spe­cial­izes in T …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA